Julio López Bastida-rekin lankidetzan egindako argitalpenak (7)

2023

  1. Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease

    European Journal of Health Economics, Vol. 24, Núm. 2, pp. 247-277

2021

  1. Assessing the effect of including social costs in economic evaluations of diabetes-related interventions: A systematic review

    ClinicoEconomics and Outcomes Research, Vol. 13, pp. 307-334

  2. Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis

    Value in Health, Vol. 24, Núm. 3, pp. 431-442

  3. Correction to: How relevant are social costs in economic evaluations? The case of Alzheimer’s disease (The European Journal of Health Economics, (2019), 20, 8, (1207-1236), 10.1007/s10198-019-01087-6)

    European Journal of Health Economics

  4. Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

2020

  1. Considering the societal perspective in economic evaluations: a systematic review in the case of depression

    Health Economics Review, Vol. 10, Núm. 1

2019

  1. How relevant are social costs in economic evaluations? The case of Alzheimer’s disease

    European Journal of Health Economics, Vol. 20, Núm. 8, pp. 1207-1236